Medpace Holdings Inc
MEDP590.090USD
-1.230-0.21%
收盘 11/14, 16:00（美东）报价延迟15分钟
16.58B总市值
38.29市盈率 TTM
关于 Medpace Holdings Inc 公司
Medpace Holdings, Inc. 是一家以科学为导向的全球性全方位临床合同研究组织 (CRO)，为生物技术、制药和医疗器械行业提供 I-IV 期临床开发服务。该公司与制药、生物技术和医疗器械公司合作开发和执行临床试验。该公司的药物开发服务专注于全方位 I-IV 期临床开发服务，包括开发计划设计、协调中心实验室、项目管理、监管事务、临床监测、数据管理和分析、药物警戒新药申请提交和上市后临床支持。该公司还为临床试验提供生物分析实验室服务、临床人体药理学、成像服务和心电图阅读支持。该公司的业务主要位于北美、欧洲和亚洲。
Medpace Holdings Inc简介
公司代码MEDP
公司名称Medpace Holdings Inc
上市日期Aug 11, 2016
CEODr. August J. Troendle, M.D.
员工数量5900
证券类型Ordinary Share
年结日Aug 11
公司地址5375 Medpace Way
城市CINCINNATI
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编45227-1543
电话15135799911
网址https://investor.medpace.com/
公司代码MEDP
上市日期Aug 11, 2016
CEODr. August J. Troendle, M.D.
Medpace Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. August J. Troendle, M.D.
Dr. August J. Troendle, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
914.16K
-1.13%
Mr. Brian T. Carley
Mr. Brian T. Carley
Independent Director
Independent Director
26.28K
+0.24%
Mr. Jesse J. Geiger, CPA
Mr. Jesse J. Geiger, CPA
President
President
15.00K
-58.91%
Mr. Stephen P. Ewald, J.D.
Mr. Stephen P. Ewald, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
13.34K
+29.01%
Mr. Robert O. Kraft
Mr. Robert O. Kraft
Independent Director
Independent Director
890.00
+6.84%
Dr. Dani S. Zander
Dr. Dani S. Zander
Independent Director
Independent Director
--
--
Mr. Cornelius P. Mccarthy, III
Mr. Cornelius P. Mccarthy, III
Independent Director
Independent Director
--
--
Mr. Kevin M. Brady
Mr. Kevin M. Brady
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Fred B. Davenport, Jr.
Mr. Fred B. Davenport, Jr.
Lead Independent Director
Lead Independent Director
--
--
Ms. Susan E. Burwig
Ms. Susan E. Burwig
Executive Vice President - Operations
Executive Vice President - Operations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. August J. Troendle, M.D.
Dr. August J. Troendle, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
914.16K
-1.13%
Mr. Brian T. Carley
Mr. Brian T. Carley
Independent Director
Independent Director
26.28K
+0.24%
Mr. Jesse J. Geiger, CPA
Mr. Jesse J. Geiger, CPA
President
President
15.00K
-58.91%
Mr. Stephen P. Ewald, J.D.
Mr. Stephen P. Ewald, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
13.34K
+29.01%
Mr. Robert O. Kraft
Mr. Robert O. Kraft
Independent Director
Independent Director
890.00
+6.84%
Dr. Dani S. Zander
Dr. Dani S. Zander
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
业务USD
名称
营收
占比
Oncology
188.56M
31.25%
Metabolic
147.87M
24.51%
Other
118.06M
19.57%
Central Nervous System
61.13M
10.13%
Cardiology
58.58M
9.71%
AVAI
29.11M
4.82%
暂无数据
业务
地区
业务USD
名称
营收
占比
Oncology
188.56M
31.25%
Metabolic
147.87M
24.51%
Other
118.06M
19.57%
Central Nervous System
61.13M
10.13%
Cardiology
58.58M
9.71%
AVAI
29.11M
4.82%
股东统计
更新时间: 5 小时前
更新时间: 5 小时前
持股股东
股东类型
持股股东
持股股东
占比
Medpace Investors, L.L.C.
16.80%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
7.47%
AQR Capital Management, LLC
3.64%
Wasatch Global Investors Inc
3.29%
其他
60.71%
持股股东
持股股东
占比
Medpace Investors, L.L.C.
16.80%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
7.47%
AQR Capital Management, LLC
3.64%
Wasatch Global Investors Inc
3.29%
其他
60.71%
股东类型
持股股东
占比
Investment Advisor
47.29%
Investment Advisor/Hedge Fund
25.63%
Corporation
16.80%
Hedge Fund
7.30%
Research Firm
4.31%
Individual Investor
3.73%
Pension Fund
2.61%
Family Office
1.65%
Family Office
1.65%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1221
26.75M
94.97%
-1.63M
2025Q2
1184
32.22M
114.46%
-1.64M
2025Q1
1189
32.19M
111.84%
-1.65M
2024Q4
1154
31.87M
104.30%
-1.77M
2024Q3
1089
31.75M
102.26%
-1.23M
2024Q2
1042
31.55M
102.01%
-1.83M
2024Q1
995
31.67M
102.27%
-1.17M
2023Q4
938
31.80M
103.67%
-407.87K
2023Q3
885
31.39M
102.53%
-1.87M
2023Q2
840
32.05M
105.05%
-2.06M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Medpace Investors, L.L.C.
4.73M
16.85%
--
--
Mar 20, 2025
The Vanguard Group, Inc.
2.38M
8.49%
-142.86K
-5.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.22M
7.89%
-198.04K
-8.20%
Jun 30, 2025
AQR Capital Management, LLC
621.18K
2.21%
+81.64K
+15.13%
Jun 30, 2025
Wasatch Global Investors Inc
945.81K
3.37%
+116.35K
+14.03%
Jun 30, 2025
Troendle (August J)
924.60K
3.29%
-1.20K
-0.13%
Sep 02, 2025
State Street Investment Management (US)
706.78K
2.52%
-76.21K
-9.73%
Jun 30, 2025
Mawer Investment Management Ltd.
817.43K
2.91%
+121.21K
+17.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
637.93K
2.27%
-30.28K
-4.53%
Jun 30, 2025
D. E. Shaw & Co., L.P.
343.56K
1.22%
+129.38K
+60.41%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Invesco Dorsey Wright Healthcare Momentum ETF
5.26%
Franklin Genomic Advancements ETF
5.07%
Argent Mid Cap ETF
4.57%
Invesco S&P MidCap Quality ETF
3.79%
Congress SMid Growth ETF
3.24%
ERShares Entrepreneurs ETF
3.24%
Janus Henderson Small/Mid Cap Growth Alpha ETF
3.08%
Invesco S&P MidCap 400 GARP ETF
2.97%
Aztlan Global Stock Selection DM SMID ETF
2.31%
Pacer US Large Cap Cash Cows Growth Leaders ETF
2.14%
查看更多
Invesco Dorsey Wright Healthcare Momentum ETF
占比5.26%
Franklin Genomic Advancements ETF
占比5.07%
Argent Mid Cap ETF
占比4.57%
Invesco S&P MidCap Quality ETF
占比3.79%
Congress SMid Growth ETF
占比3.24%
ERShares Entrepreneurs ETF
占比3.24%
Janus Henderson Small/Mid Cap Growth Alpha ETF
占比3.08%
Invesco S&P MidCap 400 GARP ETF
占比2.97%
Aztlan Global Stock Selection DM SMID ETF
占比2.31%
Pacer US Large Cap Cash Cows Growth Leaders ETF
占比2.14%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
